Literature DB >> 7989475

Obstructive sleep apnea in obese noninsulin-dependent diabetic patients: effect of continuous positive airway pressure treatment on insulin responsiveness.

B Brooks1, P A Cistulli, M Borkman, G Ross, S McGhee, R R Grunstein, C E Sullivan, D K Yue.   

Abstract

Patients with noninsulin-dependent diabetes mellitus (NIDDM) are often obese and frequently complain of tiredness. These features are also characteristically seen in patients with obstructive sleep apnea (OSA). Therefore, it was the aim of this study to assess the prevalence of OSA among a group of obese NIDDM patients who have some clinical features of OSA. The effect of reversal of OSA by nasal continuous positive airway pressure (CPAP) treatment on insulin responsiveness was also investigated. From a population of 179 NIDDM patients with a body mass index (BMI) greater than 35 kg/m2, we performed ambulatory sleep monitoring on 31 (15 males and 16 females) who admitted to either heavy snoring or excessive sleepiness. Results were reviewed by a sleep physician blinded to the clinical status of the patients, and 22 (70%) were found to have moderate or severe OSA, with mean oxygen desaturation indexes of 10.3 +/- 5.3 and 30.7 +/- 13.2 episodes/h, respectively. A subgroup of 10 patients (seven males and three females) with a mean BMI of 42.7 +/- 4.3 kg/m2 was treated with nightly CPAP for 4 months. These subjects all had significant OSA, with frequent obstructive apneas (mean, 47 +/- 31.6 episodes/h) and oxygen desaturation (mean minimum O2 saturation, 74 +/- 9.5%), as determined by polysomnography. One patient was excluded from analysis because of infrequent use of CPAP. Insulin responsiveness in terms of glucose disposal measured by hyperinsulinemic euglycemic clamps improved from 11.4 +/- 6.2 to 15.1 +/- 4.6 mumol/kg.min (P < 0.05) during CPAP treatment. These results indicate that OSA occurs commonly in obese NIDDM patients with excessive sleepiness or heavy snoring. Treatment of their OSA may improve insulin responsiveness.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7989475     DOI: 10.1210/jcem.79.6.7989475

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  76 in total

Review 1.  "Syndrome Z": the interaction of sleep apnoea, vascular risk factors and heart disease.

Authors:  I Wilcox; S G McNamara; F L Collins; R R Grunstein; C E Sullivan
Journal:  Thorax       Date:  1998-10       Impact factor: 9.139

2.  Diabetes sleep treatment trial: Premise, design, and methodology.

Authors:  Eileen R Chasens; Charles W Atwood; Lora E Burke; Mary Korytkowski; Robert Stansbury; Patrick J Strollo; Susan M Sereika
Journal:  Contemp Clin Trials       Date:  2018-12-02       Impact factor: 2.226

3.  Effect of continuous positive airway pressure therapy on glucose control.

Authors:  Salim Surani; Shyam Subramanian
Journal:  World J Diabetes       Date:  2012-04-15

Review 4.  Translational approaches to understanding metabolic dysfunction and cardiovascular consequences of obstructive sleep apnea.

Authors:  Luciano F Drager; Vsevolod Y Polotsky; Christopher P O'Donnell; Sergio L Cravo; Geraldo Lorenzi-Filho; Benedito H Machado
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

5.  Follow-up on metabolic markers in children treated for obstructive sleep apnea.

Authors:  Karen A Waters; Sinthu Sitha; Louise M O'brien; Sherryn Bibby; Carina de Torres; Silvano Vella; Roland de la Eva
Journal:  Am J Respir Crit Care Med       Date:  2006-05-18       Impact factor: 21.405

Review 6.  Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.

Authors:  Brian D Kent; Walter T McNicholas; Silke Ryan
Journal:  J Thorac Dis       Date:  2015-08       Impact factor: 2.895

Review 7.  Sleep Duration and Diabetes Risk: Population Trends and Potential Mechanisms.

Authors:  Michael A Grandner; Azizi Seixas; Safal Shetty; Sundeep Shenoy
Journal:  Curr Diab Rep       Date:  2016-11       Impact factor: 4.810

8.  Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes.

Authors:  Renee S Aronsohn; Harry Whitmore; Eve Van Cauter; Esra Tasali
Journal:  Am J Respir Crit Care Med       Date:  2009-12-17       Impact factor: 21.405

Review 9.  Sleep-disordered breathing and obesity: pathophysiology, complications, and treatment.

Authors:  Corey J Leinum; John M Dopp; Barbara J Morgan
Journal:  Nutr Clin Pract       Date:  2009-12       Impact factor: 3.080

Review 10.  Pathophysiology of sleep apnea.

Authors:  Jerome A Dempsey; Sigrid C Veasey; Barbara J Morgan; Christopher P O'Donnell
Journal:  Physiol Rev       Date:  2010-01       Impact factor: 37.312

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.